Main Catalog

Found 110

Sort by

Member $399.00

Non-Member $499.00

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition - Professional Version

Contact Hours: 8.75 (0.875 CEUs). The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.

Fundamentals of Managed Care Pharmacy

Member $199.00

Non-Member $249.00

Fundamentals of Managed Care Pharmacy Certificate Program 2nd Edition | Student Version

The Fundamentals of Managed Care Pharmacy Certificate Program provides a comprehensive introduction to basic concepts in managed care pharmacy.

Fundamentals of Managed Care Pharmacy

Member Free

Non-Member Free

Biosimilars Basics and Beyond: The Science of Biosimilars Home Study

Contact Hours: 1.0 Biosimilars have the potential to produce significant health care cost savings in the United States and improve patient access to treatment options.

Free Home Study

Member Free

Non-Member $30.00

Understanding MACRA and the Impact of Medication Use on Quality Payment Program Performance Measures

CPE 1.5 | 1.5 AMA PRA | Nurse 1.5 Contact Hours | As part of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), providers have two options to participate in Part B that will determine how they are reimbursed through the new Quality Payment Program— (APMs) or (MIPS).

Hospital/Health Systems

Member Free

Non-Member $30.00

Treating Opioid Use Disorder and Reversing Opioid Overdose

Contact Hours: 1.5. Participants should claim continuing pharmacy education (CPE) credit for this home study activity, only if they have not claimed credit for the live activity presented at AMCP Nexus 2016.

Opioid

Member Free

Non-Member $30.00

Treating Hormone Receptor-Positive Breast Cancer: A Brave New World

Oncology

Member Free

Non-Member $30.00

The Present and Future of Oncology Care Management

Contact Hours: 1.25. Participants should claim continuing pharmacy education (CPE) credit for this home study activity, only if they have not claimed credit for the live activity presented at AMCP Annual Meeting 2017.

Oncology

Member Free

Non-Member $30.00

The New Medicaid Managed Care Rule: Implications for Pharmacy Programs

CMS

Member Free

Non-Member $30.00

The Basics of Mobile Health (mHealth) and Its Potential Impact

Health IT

Member Free

Non-Member $30.00

Tackling the Opioid Epidemic and Addiction Treatment: A Managed Care Approach

Opioid

Member Free

Non-Member $30.00

Success Stories in Medical Specialty Spend Management

Specialty Pharmacy

Member Free

Non-Member $30.00

Spotlight on the Oncology Pipeline

CPE 1.5 | 1.5 AMA PRA | Nurse 1.5 Contact Hours | With the recent emphasis and success of immune checkpoint inhibitors for the treatment of various tumor types, it is tempting to assume that the oncology pipeline exclusively focuses on immunotherapies.

Oncology

Member Free

Non-Member $30.00

Specialty Pharmaceuticals in Development

Contact Hours: 1.5. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs.

Specialty Pharmacy

Member Free

Non-Member $30.00

Something Old, Something New: Medicare Audits 2017 and Beyond

CMS

Member Free

Non-Member $30.00

Rare Disease Therapies: Management Strategies to Pipeline Implications for Health Plans

Contact Hours: 1.5. The drug pipeline contains over 560 therapies in development for rare diseases.

Orphan Disease

Member Free

Non-Member $30.00

Predictive Analytics: Application to Population Health and Risk Management

Patient Care

Member Free

Non-Member $30.00

Payer & Manufacturer Communications: What’s Changed & How Does it Impact Managed Care Pharmacy?

Contact Hours: 1.5. FDA released long-awaited draft guidance clarifying the Provisions of FDAMA 114 as updated by Cures 3037, and also outlined its current thinking around preapproval information exchange (PIE).

CMS

Member Free

Non-Member $30.00

Patient-Reported Outcomes: A Primer for Managed Care Pharmacists

Patient Care

Member Free

Non-Member $30.00

NASH - Clinical Pipeline and Budget Impact Analysis

Liver Disease

Member Free

Non-Member $30.00

Medication Synchronization Programs: Adherence Solution or Fad?

Medication Synchronization

Member Free

Non-Member $30.00

Medical Benefit Medication Management - Low Hanging Fruit to Complex Strategy

Contact Hours: 1.5. Are you up to speed on the latest industry best practices in managing your medical-benefit medications?

Hospital/Health Systems

Member Free

Non-Member $30.00

Managing the Health Care Affordability Crisis: Approaches that Benefit Both the Payer and Patient

Hospital/Health Systems

Member Free

Non-Member $30.00

Managing Orphan Drugs for Rare Diseases: Challenges, Opportunities, and Value Assessment

Contact Hours: 1.5. Managing Orphan Drugs for Rare Diseases: Challenges, Opportunities and Value Assessment.

Orphan Disease

Member Free

Non-Member $30.00

Keeping up with Biosimilars: The Latest on Regulation, Utilization, Monitoring, and Pipeline

Biosimilars

Member Free

Non-Member $30.00

Interpreting the Medical Literature: Focus on Meta-Analysis

Real World Evidence

Member Free

Non-Member $30.00

Interchangeable Biologics and Biosimilars: The Federal and State Perspective

Biosimilars

Member Free

Non-Member $30.00

Incorporating Best Practices in Transgender Health Policies and Formulary Development into Your Health Plan

CPE 1.5 | 1.5 AMA PRA | Nurse 1.5 Contact Hours | The Centers for Disease Control and Prevention (CDC) estimates that an increasing number of Americans—currently, 1.4 million adults—identify as transgender.

Hospital/Health Systems

Member Free

Non-Member $30.00

Improving Treatment and Controlling Costs for Patients with Diabetes

Diabetes

Member Free

Non-Member $30.00

Improving Star Ratings Through Focused Clinical Strategy and Targeted Outreach: Results from a Systematic Approach

Contact Hours: 1.5. Star Ratings continue to evolve as measure specifications, benchmarks and inclusion into the overall calculation continue to change under Medicare.

CMS

Member Free

Non-Member $30.00

Health IT: Why it Matters to You

Health IT

Member Free

Non-Member $30.00

Global View of Value Assessment Frameworks: How Does AMCP Format 4.0 Compare?

Value Frameworks

Member Free

Non-Member $30.00

From Gaucher Disease to Tay-Sachs: Evaluating the Drug Treatment for Rare Diseases

Orphan Disease

Member Free

Non-Member $30.00

Federal and State Legislative and Regulatory Update

Contact Hours: 1.5. This must-attend session will bring you timely updates on the latest federal and state legislative and regulatory actions of interest to managed care and specialty pharmacy professionals.

Law

Member Free

Non-Member $30.00

Expanding Medication Therapy Management Beyond Medicare Part D Patients

MTM

Member Free

Non-Member $30.00

Exchange of Health Care Economic Information Between Pharmaceutical Companies and Managed Care Organizations: Current Limitations and Future Possibilities

Hospital/Health Systems

Member Free

Non-Member $30.00

Evolution of Specialty Pharmacy Services and Implications to Payers

Specialty Pharmacy

Member Free

Non-Member $30.00

Evaluating the Use of Cost Per QALY in the US Health Care System

Hospital/Health Systems

Member Free

Non-Member $30.00

Encore: Approaches to Managed Care Contracting with Pharmaceutical Manufacturers

Drug Pricing

Member Free

Non-Member $30.00

Do Value Assessment Tools Measure Up?

Hospital/Health Systems

Member Free

Non-Member $30.00

Diabetes: Value Based Insurance Designs (VBID) Real World Evidence

Contact Hours: 1.5. Self-insured employers frequently consider implementing a diabetes value-based insurance design (VBID) as a cost-effective solution for their employees.

Diabetes

Member Free

Non-Member $30.00

Current ‘State of Affairs’ of Medical Marijuana

Medical Marijuana

Member Free

Non-Member $30.00

Creating a Robust Specialty Pharmacy Network—The Payer Approach

Specialty Pharmacy

Member Free

Non-Member $30.00

Collaborative Multiple Sclerosis Care Management Approach

Contact Hours: 1.5. Multiple sclerosis is a debilitating, chronic illness and a key driver of medical and pharmacy costs.

Multiple Sclerosis

Member Free

Non-Member $30.00

Budget Impact Models: How Payers Can Build and Validate

Contact Hours: 1.5. Budget impact models (BIMs) can be built and used by payers for many decisions, including changes to the formulary.

Hospital/Health Systems

Member Free

Non-Member $30.00

Bracing for Impact: Preparing for the 2019 Specialty Drug Spend

Contact Hours: 1.5. The escalating cost of prescription drugs is an issue that continues to plague the U.S. health care system, accounting for 17% of the total health care spend in 2015.

Hospital/Health Systems

Member Free

Non-Member $30.00

Bracing for Impact: Preparing for the 2018 Specialty Drug Spend

Specialty Pharmacy

Member Free

Non-Member $30.00

Best Practices in Combating Opioid Abuse, Misuse and Diversion: The Health Plan Perspective

Contact Hours: 1.5. The opioid epidemic in the United States continues to worsen. Roughly 91 Americans die each day from an opioid overdose.

Opioid

Member Free

Non-Member $30.00

AMCP Headline Session: 2017–2018 Pharmaceutical Marketplace Trends

Not Accredited for CPE: Keeping abreast of industry trends and forecasts is vital to remaining competitive in the evolving managed care arena— especially because market predictions can shape the approach to managing the pharmacy benefit.

AMCP Headline Session 2018

Member Free

Non-Member $30.00

340B Program Evolution: Understanding Impact on Payers

340B

Member Free

Non-Member $30.00

Behavioral Economics-What does it all mean?

Hospital/Health Systems

Main Catalog

Error